Researchers from UCSD and UC Irvine have uncovered that reduced activity of ELOVL2, crucial for producing DHA, accelerates immune aging by hampering B cell development. This finding highlights how lipid imbalances may influence risks of blood cancers, urging a closer look at metabolic interventions for longevity.
Q&A
- What is the role of ELOVL2?
- How does reduced ELOVL2 activity affect immunity?
- Why is this research significant for longevity?